ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Evoke, EVERSANA Announce Commercial Launch of Gimoti? americanpharmaceuticalreview
October 30, 2020Evoke Pharma and EVERSANA? have announced the commercial launch of Gimoti? (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. -
Patheon to Manufacture FDA-Approved Nasal Spray contractpharma
July 20, 2020Evoke Pharma initiates commercial manufacturing of Gimoti with the CDMO. -
Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti NDA drugs
April 03, 2019Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food ... -
FDA rejects approval of Evoke Pharma's Gimoti for diabetic gastroparesis firstwordpharma
April 02, 2019Evoke Pharma announced Tuesday that the FDA issued a complete response letter regarding a filing under the 505(b)(2) pathway……
Pharma Sources Insight January 2025
